Crestline Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-185,766
| Closed | -$1.7M | – | 283 |
|
|
2021
Q4 | $1.7M | Buy |
185,766
+82,921
| +81% | +$757K | 0.13% | 119 |
|
|
2021
Q3 | $1.1M | Buy |
+102,845
| New | +$1.1M | 0.1% | 123 |
|
|
2018
Q3 | – | Sell |
-75,645
| Closed | -$2.94M | – | 187 |
|
|
2018
Q2 | $2.94M | Sell |
75,645
-15,271
| -17% | -$593K | 0.31% | 90 |
|
|
2018
Q1 | $2.51M | Sell |
90,916
-25,374
| -22% | -$700K | 0.31% | 44 |
|
|
2017
Q4 | $2.11M | Buy |
116,290
+76,212
| +190% | +$1.38M | 0.22% | 37 |
|
|
2017
Q3 | $647K | Buy |
40,078
+3,058
| +8% | +$49.4K | 0.09% | 116 |
|
|
2017
Q2 | $513K | Buy |
+37,020
| New | +$513K | 0.07% | 111 |
|